actively monitoring the safety of vaccines
AUSVAXSAFETY WINS DATA INNOVATION AWARD
AusVaxSafety has been awarded the Data Innovation Award at Research Australia’s 19th Annual Health and Medical Research Awards for their work in delivering a nationally consistent vaccine safety surveillance in near-real time from the first day of the COVID-19 vaccine rollout, the largest and most complex immunisation program ever delivered in Australia.
COVID VACCINE DATA
SmartVax is currently monitoring patients who have received the COVID-19 vaccine.
For the latest results on the safety surveillance of COVID-19 vaccines in use in Australia, visit AusVaxSafety.
KIDS COVID-19 VACCINE DATA
Recent data from AusVaxSafety shows children aged 5-11 years are reporting fewer side effects following COVID-19 vaccination than older Australians, with local reactions (pain at injection site, swelling, redness and itching) followed by headache and fatigue being the most commonly reported side effects among this age group.
Find out more at AusVaxSafety.
The SmartVax team have developed a new module to better understand infant food allergies
SmartStartAllergy can be run independently or alongside SmartVax’s vaccine safety monitoring and reminder modules.
Lakeside Medical Centre
New South Wales
Parents appreciate the follow up and it is an important marketing tool for the practice. Our staff value the safety net it provides us. Thank you for allowing us to participate.